NHS should give all cancer patients personalised care
Life-changing personalised cancer treatments should be offered to all patients on the NHS as standard care and not be restricted to clinical trials, experts say.
Results from an international study show that genetic testing of tumours can boost survival and avoid unnecessary treatments. Despite the evidence, British scientists fear that the NHS will lag behind because of perceived costs.
Researchers attending the world’s largest cancer conference in Chicago hailed personalised medicine as the “future of treatment” and the “biggest breakthrough since chemotherapy”.
Clinical results gathered from thousands of patients with a range of cancer found positive results increase six-fold with